img

Global Female Contraceptives Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Female Contraceptives Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Female Contraceptives report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Female Contraceptives market is projected to reach US$ 22120 million in 2034, increasing from US$ 18390 million in 2022, with the CAGR of 2.6% during the period of 2024 to 2034. Demand from Personal use and Hospital are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Female Contraceptives industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Female Contraceptives key companies include Bayer, Mayer Laboratories, Pfizer, Mylan, Teva, Merck, Johnson & Johnson, Lupin Pharmaceuticals and Female Health Company, etc. Bayer, Mayer Laboratories, Pfizer are top 3 players and held % share in total in 2022.
Female Contraceptives can be divided into Contraceptive Drugs and Contraceptive Devices, etc. Contraceptive Drugs is the mainstream product in the market, accounting for % share globally in 2022.
Female Contraceptives is widely used in various fields, such as Personal use and Hospital, etc. Personal use provides greatest supports to the Female Contraceptives industry development. In 2022, global % share of Female Contraceptives went into Personal use filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Female Contraceptives market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Bayer
Mayer Laboratories
Pfizer
Mylan
Teva
Merck
Johnson & Johnson
Lupin Pharmaceuticals
Female Health Company
Fuji Latex
Segment by Type
Contraceptive Drugs
Contraceptive Devices

Segment by Application


Personal use
Hospital
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Female Contraceptives market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Female Contraceptives introduction, etc. Female Contraceptives Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Female Contraceptives market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Female Contraceptives
1.1 Female Contraceptives Market Overview
1.1.1 Female Contraceptives Product Scope
1.1.2 Female Contraceptives Market Status and Outlook
1.2 Global Female Contraceptives Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Female Contraceptives Market Size by Region (2024-2034)
1.4 Global Female Contraceptives Historic Market Size by Region (2024-2024)
1.5 Global Female Contraceptives Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Female Contraceptives Market Size (2024-2034)
1.6.1 North America Female Contraceptives Market Size (2024-2034)
1.6.2 Europe Female Contraceptives Market Size (2024-2034)
1.6.3 Asia-Pacific Female Contraceptives Market Size (2024-2034)
1.6.4 Latin America Female Contraceptives Market Size (2024-2034)
1.6.5 Middle East & Africa Female Contraceptives Market Size (2024-2034)
2 Female Contraceptives Market by Type
2.1 Introduction
2.1.1 Contraceptive Drugs
2.1.2 Contraceptive Devices
2.2 Global Female Contraceptives Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Female Contraceptives Historic Market Size by Type (2024-2024)
2.2.2 Global Female Contraceptives Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Female Contraceptives Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Female Contraceptives Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Female Contraceptives Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Female Contraceptives Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Female Contraceptives Revenue Breakdown by Type (2024-2034)
3 Female Contraceptives Market Overview by Application
3.1 Introduction
3.1.1 Personal use
3.1.2 Hospital
3.2 Global Female Contraceptives Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Female Contraceptives Historic Market Size by Application (2024-2024)
3.2.2 Global Female Contraceptives Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Female Contraceptives Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Female Contraceptives Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Female Contraceptives Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Female Contraceptives Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Female Contraceptives Revenue Breakdown by Application (2024-2034)
4 Female Contraceptives Competition Analysis by Players
4.1 Global Female Contraceptives Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Female Contraceptives as of 2022)
4.3 Date of Key Players Enter into Female Contraceptives Market
4.4 Global Top Players Female Contraceptives Headquarters and Area Served
4.5 Key Players Female Contraceptives Product Solution and Service
4.6 Competitive Status
4.6.1 Female Contraceptives Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bayer
5.1.1 Bayer Profile
5.1.2 Bayer Main Business
5.1.3 Bayer Female Contraceptives Products, Services and Solutions
5.1.4 Bayer Female Contraceptives Revenue (US$ Million) & (2024-2024)
5.1.5 Bayer Recent Developments
5.2 Mayer Laboratories
5.2.1 Mayer Laboratories Profile
5.2.2 Mayer Laboratories Main Business
5.2.3 Mayer Laboratories Female Contraceptives Products, Services and Solutions
5.2.4 Mayer Laboratories Female Contraceptives Revenue (US$ Million) & (2024-2024)
5.2.5 Mayer Laboratories Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer Female Contraceptives Products, Services and Solutions
5.3.4 Pfizer Female Contraceptives Revenue (US$ Million) & (2024-2024)
5.3.5 Mylan Recent Developments
5.4 Mylan
5.4.1 Mylan Profile
5.4.2 Mylan Main Business
5.4.3 Mylan Female Contraceptives Products, Services and Solutions
5.4.4 Mylan Female Contraceptives Revenue (US$ Million) & (2024-2024)
5.4.5 Mylan Recent Developments
5.5 Teva
5.5.1 Teva Profile
5.5.2 Teva Main Business
5.5.3 Teva Female Contraceptives Products, Services and Solutions
5.5.4 Teva Female Contraceptives Revenue (US$ Million) & (2024-2024)
5.5.5 Teva Recent Developments
5.6 Merck
5.6.1 Merck Profile
5.6.2 Merck Main Business
5.6.3 Merck Female Contraceptives Products, Services and Solutions
5.6.4 Merck Female Contraceptives Revenue (US$ Million) & (2024-2024)
5.6.5 Merck Recent Developments
5.7 Johnson & Johnson
5.7.1 Johnson & Johnson Profile
5.7.2 Johnson & Johnson Main Business
5.7.3 Johnson & Johnson Female Contraceptives Products, Services and Solutions
5.7.4 Johnson & Johnson Female Contraceptives Revenue (US$ Million) & (2024-2024)
5.7.5 Johnson & Johnson Recent Developments
5.8 Lupin Pharmaceuticals
5.8.1 Lupin Pharmaceuticals Profile
5.8.2 Lupin Pharmaceuticals Main Business
5.8.3 Lupin Pharmaceuticals Female Contraceptives Products, Services and Solutions
5.8.4 Lupin Pharmaceuticals Female Contraceptives Revenue (US$ Million) & (2024-2024)
5.8.5 Lupin Pharmaceuticals Recent Developments
5.9 Female Health Company
5.9.1 Female Health Company Profile
5.9.2 Female Health Company Main Business
5.9.3 Female Health Company Female Contraceptives Products, Services and Solutions
5.9.4 Female Health Company Female Contraceptives Revenue (US$ Million) & (2024-2024)
5.9.5 Female Health Company Recent Developments
5.10 Fuji Latex
5.10.1 Fuji Latex Profile
5.10.2 Fuji Latex Main Business
5.10.3 Fuji Latex Female Contraceptives Products, Services and Solutions
5.10.4 Fuji Latex Female Contraceptives Revenue (US$ Million) & (2024-2024)
5.10.5 Fuji Latex Recent Developments
6 North America
6.1 North America Female Contraceptives Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Female Contraceptives Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Female Contraceptives Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Female Contraceptives Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Female Contraceptives Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Female Contraceptives Market Dynamics
11.1 Female Contraceptives Industry Trends
11.2 Female Contraceptives Market Drivers
11.3 Female Contraceptives Market Challenges
11.4 Female Contraceptives Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Female Contraceptives Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Female Contraceptives Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Female Contraceptives Market Size Share by Region (2024-2024)
Table 4. Global Female Contraceptives Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Female Contraceptives Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Female Contraceptives Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Female Contraceptives Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Female Contraceptives Revenue Market Share by Type (2024-2024)
Table 9. Global Female Contraceptives Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Female Contraceptives Revenue Market Share by Type (2024-2034)
Table 11. North America Female Contraceptives Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Female Contraceptives Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Female Contraceptives Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Female Contraceptives Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Female Contraceptives Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Female Contraceptives Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Female Contraceptives Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Female Contraceptives Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Female Contraceptives Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Female Contraceptives Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Female Contraceptives Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Female Contraceptives Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Female Contraceptives Revenue Market Share by Application (2024-2024)
Table 24. Global Female Contraceptives Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Female Contraceptives Revenue Market Share by Application (2024-2034)
Table 26. North America Female Contraceptives Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Female Contraceptives Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Female Contraceptives Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Female Contraceptives Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Female Contraceptives Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Female Contraceptives Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Female Contraceptives Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Female Contraceptives Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Female Contraceptives Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Female Contraceptives Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Female Contraceptives Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Female Contraceptives Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Female Contraceptives as of 2022)
Table 39. Date of Key Players Enter into Female Contraceptives Market
Table 40. Global Female Contraceptives Key Players Headquarters and Area Served
Table 41. Female Contraceptives Product Solution and Service
Table 42. Global Female Contraceptives Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Bayer Basic Information List
Table 45. Bayer Description and Business Overview
Table 46. Bayer Female Contraceptives Products, Services and Solutions
Table 47. Revenue (US$ Million) in Female Contraceptives Business of Bayer (2024-2024)
Table 48. Bayer Recent Developments
Table 49. Mayer Laboratories Basic Information List
Table 50. Mayer Laboratories Description and Business Overview
Table 51. Mayer Laboratories Female Contraceptives Products, Services and Solutions
Table 52. Revenue (US$ Million) in Female Contraceptives Business of Mayer Laboratories (2024-2024)
Table 53. Mayer Laboratories Recent Developments
Table 54. Pfizer Basic Information List
Table 55. Pfizer Description and Business Overview
Table 56. Pfizer Female Contraceptives Products, Services and Solutions
Table 57. Revenue (US$ Million) in Female Contraceptives Business of Pfizer (2024-2024)
Table 58. Pfizer Recent Developments
Table 59. Mylan Basic Information List
Table 60. Mylan Description and Business Overview
Table 61. Mylan Female Contraceptives Products, Services and Solutions
Table 62. Revenue (US$ Million) in Female Contraceptives Business of Mylan (2024-2024)
Table 63. Mylan Recent Developments
Table 64. Teva Basic Information List
Table 65. Teva Description and Business Overview
Table 66. Teva Female Contraceptives Products, Services and Solutions
Table 67. Revenue (US$ Million) in Female Contraceptives Business of Teva (2024-2024)
Table 68. Teva Recent Developments
Table 69. Merck Basic Information List
Table 70. Merck Description and Business Overview
Table 71. Merck Female Contraceptives Products, Services and Solutions
Table 72. Revenue (US$ Million) in Female Contraceptives Business of Merck (2024-2024)
Table 73. Merck Recent Developments
Table 74. Johnson & Johnson Basic Information List
Table 75. Johnson & Johnson Description and Business Overview
Table 76. Johnson & Johnson Female Contraceptives Products, Services and Solutions
Table 77. Revenue (US$ Million) in Female Contraceptives Business of Johnson & Johnson (2024-2024)
Table 78. Johnson & Johnson Recent Developments
Table 79. Lupin Pharmaceuticals Basic Information List
Table 80. Lupin Pharmaceuticals Description and Business Overview
Table 81. Lupin Pharmaceuticals Female Contraceptives Products, Services and Solutions
Table 82. Revenue (US$ Million) in Female Contraceptives Business of Lupin Pharmaceuticals (2024-2024)
Table 83. Lupin Pharmaceuticals Recent Developments
Table 84. Female Health Company Basic Information List
Table 85. Female Health Company Description and Business Overview
Table 86. Female Health Company Female Contraceptives Products, Services and Solutions
Table 87. Revenue (US$ Million) in Female Contraceptives Business of Female Health Company (2024-2024)
Table 88. Female Health Company Recent Developments
Table 89. Fuji Latex Basic Information List
Table 90. Fuji Latex Description and Business Overview
Table 91. Fuji Latex Female Contraceptives Products, Services and Solutions
Table 92. Revenue (US$ Million) in Female Contraceptives Business of Fuji Latex (2024-2024)
Table 93. Fuji Latex Recent Developments
Table 94. North America Female Contraceptives Market Size by Country (2024-2024) & (US$ Million)
Table 95. North America Female Contraceptives Market Size by Country (2024-2034) & (US$ Million)
Table 96. Europe Female Contraceptives Market Size by Country (2024-2024) & (US$ Million)
Table 97. Europe Female Contraceptives Market Size by Country (2024-2034) & (US$ Million)
Table 98. Asia-Pacific Female Contraceptives Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 99. Asia-Pacific Female Contraceptives Market Size by Region (2024-2024) & (US$ Million)
Table 100. Asia-Pacific Female Contraceptives Market Size by Region (2024-2034) & (US$ Million)
Table 101. Asia-Pacific Female Contraceptives Market Share by Region (2024-2024)
Table 102. Asia-Pacific Female Contraceptives Market Share by Region (2024-2034)
Table 103. Latin America Female Contraceptives Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 104. Latin America Female Contraceptives Market Size by Country (2024-2024) & (US$ Million)
Table 105. Latin America Female Contraceptives Market Size by Country (2024-2034) & (US$ Million)
Table 106. Middle East & Africa Female Contraceptives Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 107. Middle East & Africa Female Contraceptives Market Size by Country (2024-2024) & (US$ Million)
Table 108. Middle East & Africa Female Contraceptives Market Size by Country (2024-2034) & (US$ Million)
Table 109. Female Contraceptives Market Trends
Table 110. Female Contraceptives Market Drivers
Table 111. Female Contraceptives Market Challenges
Table 112. Female Contraceptives Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Female Contraceptives Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Female Contraceptives Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Female Contraceptives Market Share by Regions: 2022 VS 2034
Figure 4. Global Female Contraceptives Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Female Contraceptives Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Female Contraceptives Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Female Contraceptives Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Female Contraceptives Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Female Contraceptives Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Contraceptive Drugs
Figure 11. Global Contraceptive Drugs Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Contraceptive Devices
Figure 13. Global Contraceptive Devices Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Global Female Contraceptives Market Size Share by Type: 2022 & 2034
Figure 15. North America Female Contraceptives Revenue Market Share by Type (2024-2034)
Figure 16. Europe Female Contraceptives Revenue Market Share by Type (2024-2034)
Figure 17. Asia-Pacific Female Contraceptives Revenue Market Share by Type (2024-2034)
Figure 18. Latin America Female Contraceptives Revenue Market Share by Type (2024-2034)
Figure 19. Middle East and Africa Female Contraceptives Revenue Market Share by Type (2024-2034)
Figure 20. Personal use Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 21. Hospital Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 22. Global Female Contraceptives Market Size Share by Application: 2022 & 2034
Figure 23. North America Female Contraceptives Revenue Market Share by Application (2024-2034)
Figure 24. Europe Female Contraceptives Revenue Market Share by Application (2024-2034)
Figure 25. Asia-Pacific Female Contraceptives Revenue Market Share by Application (2024-2034)
Figure 26. Latin America Female Contraceptives Revenue Market Share by Application (2024-2034)
Figure 27. Middle East and Africa Female Contraceptives Revenue Market Share by Application (2024-2034)
Figure 28. Female Contraceptives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 29. Global Top 5 and Top 10 Players Female Contraceptives Market Share in 2022
Figure 30. North America Female Contraceptives Market Share by Country (2024-2034)
Figure 31. U.S. Female Contraceptives Market Size (2024-2034) & (US$ Million)
Figure 32. Canada Female Contraceptives Market Size (2024-2034) & (US$ Million)
Figure 33. Germany Female Contraceptives Market Size (2024-2034) & (US$ Million)
Figure 34. France Female Contraceptives Market Size (2024-2034) & (US$ Million)
Figure 35. U.K. Female Contraceptives Market Size (2024-2034) & (US$ Million)
Figure 36. Italy Female Contraceptives Market Size (2024-2034) & (US$ Million)
Figure 37. Russia Female Contraceptives Market Size (2024-2034) & (US$ Million)
Figure 38. Nordic Countries Female Contraceptives Market Size (2024-2034) & (US$ Million)
Figure 39. Asia-Pacific Female Contraceptives Market Share by Region (2024-2034)
Figure 40. China Female Contraceptives Market Size (2024-2034) & (US$ Million)
Figure 41. Japan Female Contraceptives Market Size (2024-2034) & (US$ Million)
Figure 42. South Korea Female Contraceptives Market Size (2024-2034) & (US$ Million)
Figure 43. Southeast Asia Female Contraceptives Market Size (2024-2034) & (US$ Million)
Figure 44. India Female Contraceptives Market Size (2024-2034) & (US$ Million)
Figure 45. Australia Female Contraceptives Market Size (2024-2034) & (US$ Million)
Figure 46. Latin America Female Contraceptives Market Share by Country (2024-2034)
Figure 47. Mexico Female Contraceptives Market Size (2024-2034) & (US$ Million)
Figure 48. Brazil Female Contraceptives Market Size (2024-2034) & (US$ Million)
Figure 49. Middle East & Africa Female Contraceptives Market Share by Country (2024-2034)
Figure 50. Turkey Female Contraceptives Market Size (2024-2034) & (US$ Million)
Figure 51. Saudi Arabia Female Contraceptives Market Size (2024-2034) & (US$ Million)
Figure 52. UAE Female Contraceptives Market Size (2024-2034) & (US$ Million)
Figure 53. Bottom-up and Top-down Approaches for This Report